Keywords: مهارکننده Dipeptidyl peptidase-4; dipeptidyl peptidase-4 inhibitor; drug-drug interactions; metformin; pharmacokinetics; teneligliptin;
مقالات ISI مهارکننده Dipeptidyl peptidase-4 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مهارکننده Dipeptidyl peptidase-4; A1C; glycated hemoglobin; DPP-4i; dipeptidyl peptidase-4 inhibitor; DURATION-8; Diabetes Therapy Utilization: Researching Changes in A1C, Weight and Other Factors Through Intervention with Exenatide Once Weekly-8; GLP-1; glucagon-like peptide-1; GLP-1RA;
Keywords: مهارکننده Dipeptidyl peptidase-4; ATC; Anatomical Therapeutic Chemical; CI; confidence interval; CKD; chronic kidney disease; COPD; chronic obstructive pulmonary disease; CVD; cardiovascular disease; DPP4i; dipeptidyl peptidase-4 inhibitor; HR; hazard ratio; ICD-10; International Classifi
Keywords: مهارکننده Dipeptidyl peptidase-4; dipeptidyl peptidase-4 inhibitor; heart failure; network meta-analysis; type 2 diabetes mellitus;
Keywords: مهارکننده Dipeptidyl peptidase-4; Dipeptidyl peptidase-4 inhibitor; elderly; diabetes mellitus; major adverse cardiovascular events; mortality;
Keywords: مهارکننده Dipeptidyl peptidase-4; Linagliptin; Dipeptidyl peptidase-4 inhibitor; Type 2 diabetes mellitus; Coronary artery disease; Drug safety; Heart failure;
Keywords: مهارکننده Dipeptidyl peptidase-4; Dipeptidyl peptidase-4 inhibitor; Ramadan fasting; Sulphonylurea; Type 2 diabetes mellitus;
Keywords: مهارکننده Dipeptidyl peptidase-4; Dipeptidyl peptidase-4 inhibitor; Insulin; Meta-analysis; Systematic review; Type 2 diabetes;
Keywords: مهارکننده Dipeptidyl peptidase-4; Type 2 diabetes mellitus; Dipeptidyl peptidase-4 inhibitor; Chronic kidney disease; Diabetic nephropathy; Estimated glomerular filtration rate; Albuminuria
Keywords: مهارکننده Dipeptidyl peptidase-4; cost-effectiveness; dipeptidyl peptidase-4 inhibitor; SGLT2 inhibitor; type 2 diabetes;
Keywords: مهارکننده Dipeptidyl peptidase-4; DPP-4; dipeptidyl peptidase-4; GLP-1; glucagon-like peptide-1; SD; Sprague-Dawley; NF-κB; nuclear factor-κB; GIP; gastric inhibitory polypeptide; ICAM-1; intercellular adhesion molecule-1; PAM; periodic acid-methenamine silver; cAMP; cyclic AMP; CRP;
Keywords: مهارکننده Dipeptidyl peptidase-4; Cardiovascular disease; Dipeptidyl peptidase-4 inhibitor; Dyslipidemia; Incretin; Statin;
Keywords: مهارکننده Dipeptidyl peptidase-4; dipeptidyl peptidase-4 inhibitor; drug-drug interactions; ketoconazole; pharmacokinetics; teneligliptin;
HLA-DQB1*03:01 as a Biomarker for Genetic Susceptibility to Bullous Pemphigoid Induced by DPP-4 Inhibitors
Keywords: مهارکننده Dipeptidyl peptidase-4; BP; bullous pemphigoid; BPDAI; Bullous Pemphigoid Disease Area Index; COL17; type XVII collagen; DPP-4i; dipeptidyl peptidase-4 inhibitor;
Hypoglycaemia in the over 75s: Understanding the predisposing factors in type 2 diabetes (T2DM)
Keywords: مهارکننده Dipeptidyl peptidase-4; GP; general practitioner; EMIS; Egton Medical Information Systems; BMI; body mass index; HbA1c; glycated haemoglobin; eGFR; estimated glomerular filtration rate; DM; diabetes mellitus; IHD; ischaemic heart disease; (TIA); transient ischaemic attack; (DPP-
Vildagliptin Significantly Increases the Risk of Bullous Pemphigoid: A Finnish Nationwide Registry Study
Keywords: مهارکننده Dipeptidyl peptidase-4; BP; bullous pemphigoid; DPP-4i; dipeptidyl peptidase-4 inhibitor;
The persistent inhibitory properties of saxagliptin on renal dipeptidyl peptidase-4: Studies with HK-2 cells in vitro and normal rats in vivo
Keywords: مهارکننده Dipeptidyl peptidase-4; Dipeptidyl peptidase-4 inhibitor; Saxagliptin; Sitagliptin; Renal dipeptidyl peptidase-4; Renal tubular cells;
Effects of alogliptin on fractional flow reserve evaluated by coronary computed tomography angiography in patients with type 2 diabetes: Rationale and design of the TRACT study
Keywords: مهارکننده Dipeptidyl peptidase-4; Alogliptin; Coronary atherosclerosis; Coronary computed tomography angiography; Dipeptidyl peptidase-4 inhibitor; Fractional flow reserve;
Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin on Atherosclerosis, β-Cell Function, and Glycemic Control in Japanese Patients with Type 2 Diabetes Mellitus Who are Treatment Naïve or Poorly Responsive to Antidiabetes Agents: A M
Keywords: مهارکننده Dipeptidyl peptidase-4; pentraxin-3; dipeptidyl peptidase-4 inhibitor; sitagliptin; proinsulin/insulin ratio;
Short-term therapy with combination dipeptidyl peptidase-4 inhibitor saxagliptin/metformin extended release (XR) is superior to saxagliptin or metformin XR monotherapy in prediabetic women with polycystic ovary syndrome: a single-blind, randomized, pilot
Keywords: مهارکننده Dipeptidyl peptidase-4; Dipeptidyl peptidase-4 inhibitor; polycystic ovary syndrome; prediabetic hyperglycemia; saxagliptin;
Efficacy and safety of DPP-4 inhibitors in patients with type 2 diabetes: Meta-analysis of placebo-controlled randomized clinical trials
Keywords: مهارکننده Dipeptidyl peptidase-4; DPP-4 inhibitors; Meta-analysis; Micro- and macrovascular complications; Mortality; Randomized clinical trials; Type 2 diabetes; CI; confidence interval; EXAMINE; Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care; FDA; Food an
Second line initiation of insulin compared with DPP-4 inhibitors after metformin monotherapy is associated with increased risk of all-cause mortality, cardiovascular events, and severe hypoglycemia
Keywords: مهارکننده Dipeptidyl peptidase-4; Insulin; Type 2 diabetes; Dipeptidyl peptidase-4 inhibitor; Cardiovascular disease; Hypoglycemia; Outcome;
Effects of DPP-4 inhibitors on cardiovascular outcomes in patients with type 2 diabetes and end-stage renal disease
Keywords: مهارکننده Dipeptidyl peptidase-4; Dipeptidyl peptidase-4 inhibitor; End-stage renal disease; Diabetes mellitus; Major adverse cardiovascular events; Mortality;
Cardiac DPP-4 inhibition by saxagliptin ameliorates isoproterenol-induced myocardial remodeling and cardiac diastolic dysfunction in rats
Keywords: مهارکننده Dipeptidyl peptidase-4; Dipeptidyl peptidase-4 inhibitor; Saxagliptin; Myocardial remodeling; Cardiac diastolic dysfunction; Cardiac dipeptidyl peptidase-4;
Patient engagement impacts glycemic management with vildagliptin and vildagliptin/metformin (single pill) regimens in type 2 diabetes mellitus (the GLORIOUS study)
Keywords: مهارکننده Dipeptidyl peptidase-4; Type 2 diabetes mellitus; Diabetes mellitus; Vildagliptin; Dipeptidyl peptidase-4 inhibitor; Outcomes; Effectiveness;
Oleic acid stimulates glucagon-like peptide-1 release from enteroendocrine cells by modulating cell respiration and glycolysis
Keywords: مهارکننده Dipeptidyl peptidase-4; GLP-1; glucagon like peptide-1; OA; sodium salt of oleic acid; EC; enteroendocrine cells; GPR; G protein-coupled receptors; FAT; fatty acid transporters; CD36; class B scavenger receptor cluster-of-differentiation 36/fatty acid translocase; XF24; Seahorse
Effects of Glimepiride versus Saxagliptin on β-Cell Function and Hypoglycemia: A Post Hoc Analysis in Older Patients with Type 2 Diabetes Inadequately Controlled with Metformin
Keywords: مهارکننده Dipeptidyl peptidase-4; β-cell function; dipeptidyl peptidase-4 inhibitor; homeostasis model assessment-2%β; saxagliptin;
DPP-4 inhibitor therapy and bone fractures in people with Type 2 diabetes - A systematic review and meta-analysis
Keywords: مهارکننده Dipeptidyl peptidase-4; Fracture; Dipeptidyl peptidase-4 inhibitor; Meta-analysis;
Pharmacological profiles of gemigliptin (LC15-0444), a novel dipeptidyl peptidase-4 inhibitor, in vitro and in vivo
Keywords: مهارکننده Dipeptidyl peptidase-4; Gemigliptin (PubChem CID: 11953153); Vildagliptin (PubChem CID: 11077541); Sitagliptin (PubChem CID: 11591741); Dipeptidyl peptidase-4 inhibitor; Gemigliptin; Incretin; Type 2 diabetes mellitus;
A dipeptidyl peptidase-4 inhibitor ameliorates hypertensive cardiac remodeling via angiotensin-II/sodium-proton pump exchanger-1 axis
Keywords: مهارکننده Dipeptidyl peptidase-4; Dipeptidyl peptidase-4 inhibitor; Hypertension; Cardiac remodeling; Angiotensin-II; Sodium-proton pump exchanger;
Effects of miglitol, sitagliptin, and initial combination therapy with both on plasma incretin responses to a mixed meal and visceral fat in over-weight Japanese patients with type 2 diabetes. “The MASTER randomized, controlled trial”
Keywords: مهارکننده Dipeptidyl peptidase-4; Gastiric inhibitory polypeptide; Obesity; Alpha-glucosidase inhibitor; Dipeptidyl peptidase-4 inhibitor; Adiponectin;
Synthesis and biological evaluation of pyrrolidine-2-carbonitrile and 4-fluoropyrrolidine-2-carbonitrile derivatives as dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes
Keywords: مهارکننده Dipeptidyl peptidase-4; Pyrrolidine-2-carbonitrile; 4-Fluoropyrrolidine-2-carbonitrile; Dipeptidyl peptidase-4 inhibitor; Oral glucose tolerance test; Type 2 diabetes;
Excretion of the dipeptidyl peptidase-4 inhibitor linagliptin in rats is primarily by biliary excretion and P-gp-mediated efflux
Keywords: مهارکننده Dipeptidyl peptidase-4; Linagliptin; Dipeptidyl peptidase-4 inhibitor; Transport; Pharmacokinetics; P-glycoprotein; Bile
Endocrine pharmacologyEffects of long-term treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin on islet endocrine cells in non-obese type 2 diabetic Goto-Kakizaki rats
Keywords: مهارکننده Dipeptidyl peptidase-4; Type 2 diabetes; Dipeptidyl peptidase-4 inhibitor; Glucagon-like peptide-1; β cells; α cells; (GK rat);
Efficacy and Tolerability of Linagliptin Added to a Sulfonylurea Regimen in Patients With Inadequately Controlled Type 2 Diabetes Mellitus: An 18-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Keywords: مهارکننده Dipeptidyl peptidase-4; add-on therapy; dipeptidyl peptidase-4 inhibitor; linagliptin; sulfonylurea; type 2 diabetes mellitus;
Dipeptidyl Peptidase-4 as a New Target of Action for Type 2 Diabetes Mellitus: A Systematic Review
Keywords: مهارکننده Dipeptidyl peptidase-4; Dipeptidyl peptidase-4 inhibitor; DPP-4 inhibitors; Sitagliptin; Vildagliptin; Diabetes type 2; Glycohemoglobin A1c; Incretins